KRTAP9-6: A Potential Drug Target and Biomarker (G100507608)

Target Name: KRTAP9-6

NCBI ID: G100507608

KRTAP9-6

KRTAP9-6: A Potential Drug Target and Biomarker

Kallikrein-related peptidases (KRTAPs) are a family of enzymes that regulate various physiological processes in the body, including blood clotting, inflammation, and tissue repair. KRTAP9-6 is a specific member of this family that has been identified as a potential drug target and biomarker.

The discovery of KRTAP9-6

KRTAP9-6 was first identified as a gene in the database of gene expression in the University of California, San Diego (UCSD) School of Medicine. The gene was identified based on its expression in various human tissues, including blood, skin, and pancreas.

The function of KRTAP9-6

KRTAP9-6 is a member of the Kallikrein-related peptidases (KRTAP) family, which are a group of enzymes that belong to the serine protease family 11. These enzymes are involved in the regulation of various physiological processes in the body, including blood clotting, inflammation, and tissue repair.

KRTAP9-6 is involved in the regulation of platelet function, which is a critical aspect of blood clotting. Plasma platelets are responsible for forming blood clots that help to stop bleeding in the event of an injury or surgery. KRTAP9-6 is involved in the regulation of the amount of platelets that are produced and deployed during this process.

In addition to its role in blood clotting, KRTAP9-6 is also involved in the regulation of inflammation and tissue repair. Inflammation is a critical response of the immune system to injury or infection, and it can lead to the formation of tissue repair particles. KRTAP9-6 is involved in the regulation of the clearance of these repair particles by the immune system.

The potential clinical applications of KRTAP9-6

The potential clinical applications of KRTAP9-6 are vast and varied. Given its involvement in the regulation of platelet function, KRTAP9-6 could be a useful target for the development of anticoagulants, which are drugs that are designed to prevent blood clots.

In addition to its potential use as an anticoagulant, KRTAP9-6 has also been identified as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Given its involvement in the regulation of platelet function, KRTAP9-6 could be used as a biomarker for the diagnosis and prognosis of these diseases.

The potential drug targets for KRTAP9-6

The potential drug targets for KRTAP9-6 are numerous and varied. Given its involvement in the regulation of platelet function, some potential drug targets for KRTAP9-6 may include:

1. Platelet function regulator: Drugs that modulate platelet function, such as those that stimulate platelet production or inhibit platelet aggregation, could be potential drug targets for KRTAP9-6.
2. Anticoagulant: Drugs that prevent blood clots could be potential drug targets for KRTAP9-6.
3. Biomarker: KRTAP9-6 has been identified as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Drugs that target KRTAP9-6 specifically or its downstream signaling pathways could be potential biomarker drugs.

Conclusion

KRTAP9-6 is a member of the Kallikrein-related peptidases (KRTAP) family that is involved in the regulation of various physiological processes in the body. Its potential clinical applications are vast and varied, including the development of anticoagulants and the diagnosis and prognosis of various diseases. Further research is needed to fully understand the role of KRTAP9-6

Protein Name: Keratin Associated Protein 9-6

Functions: In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins (By similarity)

The "KRTAP9-6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRTAP9-6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets